Parathyroid Hormone
"Parathyroid Hormone" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A polypeptide hormone (84 amino acid residues) secreted by the PARATHYROID GLANDS which performs the essential role of maintaining intracellular CALCIUM levels in the body. Parathyroid hormone increases intracellular calcium by promoting the release of CALCIUM from BONE, increases the intestinal absorption of calcium, increases the renal tubular reabsorption of calcium, and increases the renal excretion of phosphates.
Descriptor ID |
D010281
|
MeSH Number(s) |
D06.472.699.590 D12.644.548.587
|
Concept/Terms |
Parathyroid Hormone- Parathyroid Hormone
- Hormone, Parathyroid
- PTH (1-84)
- Parathyroid Hormone (1-84)
- Parathormone
- Parathyrin
|
Below are MeSH descriptors whose meaning is more general than "Parathyroid Hormone".
Below are MeSH descriptors whose meaning is more specific than "Parathyroid Hormone".
This graph shows the total number of publications written about "Parathyroid Hormone" by people in this website by year, and whether "Parathyroid Hormone" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
1997 | 0 | 1 | 1 | 2002 | 0 | 1 | 1 | 2007 | 0 | 1 | 1 | 2008 | 1 | 2 | 3 | 2010 | 0 | 2 | 2 | 2011 | 1 | 0 | 1 | 2012 | 0 | 2 | 2 | 2013 | 0 | 1 | 1 | 2015 | 0 | 2 | 2 | 2016 | 1 | 1 | 2 | 2017 | 1 | 1 | 2 | 2018 | 1 | 2 | 3 | 2020 | 0 | 2 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Parathyroid Hormone" by people in Profiles.
-
Laster M, Denburg M, Okuda Y, Kumar J, Furth S, Warady B, Kalantar-Zadeh K, Norris K, Salusky IB. Race and Ethnicity Predict Bone Markers and Fracture in Pediatric Patients With Chronic Kidney Disease. J Bone Miner Res. 2021 02; 36(2):298-304.
-
Sohn W, Salusky IB, Schmitt CP, Taylan C, Walle JV, Ngang J, Yan L, Kroenke M, Warady BA. Phase 1, single-dose study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of etelcalcetide in pediatric patients with secondary hyperparathyroidism receiving hemodialysis. Pediatr Nephrol. 2021 01; 36(1):133-142.
-
Warady BA, Iles JN, Ariceta G, Dehmel B, Hidalgo G, Jiang X, Laskin B, Shahinfar S, Vande Walle J, Schaefer F. A randomized, double-blind, placebo-controlled study to assess the efficacy and safety of cinacalcet in pediatric patients with chronic kidney disease and secondary hyperparathyroidism receiving dialysis. Pediatr Nephrol. 2019 03; 34(3):475-486.
-
Sohn WY, Portale AA, Salusky IB, Zhang H, Yan LL, Ertik B, Shahinfar S, Lee E, Dehmel B, Warady BA. An open-label, single-dose study to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of cinacalcet in pediatric subjects aged 28?days to 6?years with chronic kidney disease receiving dialysis. Pediatr Nephrol. 2019 01; 34(1):145-154.
-
VanSickle JS, Srivastava T, Alon US. Use of calcimimetics in children with normal kidney function. Pediatr Nephrol. 2019 03; 34(3):413-422.
-
Srivastava T, Jafri S, Truog WE, Sebestyen VanSickle J, Manimtim WM, Alon US. Successful Reversal of Furosemide-Induced Secondary Hyperparathyroidism With Cinacalcet. Pediatrics. 2017 Dec; 140(6).
-
Webb NJA, Lerner G, Warady BA, Dell KM, Greenbaum LA, Ariceta G, Hoppe B, Linde P, Lee HJ, Eldred A, Dufek MB. Efficacy and safety of paricalcitol in children with stages 3 to 5 chronic kidney disease. Pediatr Nephrol. 2017 Jul; 32(7):1221-1232.
-
Portale AA, Wolf MS, Messinger S, Perwad F, J?ppner H, Warady BA, Furth SL, Salusky IB. Fibroblast Growth Factor 23 and Risk of CKD Progression in Children. Clin J Am Soc Nephrol. 2016 11 07; 11(11):1989-1998.
-
Nampoothiri S, Fern?ndez-Rebollo E, Yesodharan D, Gardella TJ, Rush ET, Langman CB, J?ppner H. Jansen Metaphyseal Chondrodysplasia due to Heterozygous H223R-PTH1R Mutations With or Without Overt Hypercalcemia. J Clin Endocrinol Metab. 2016 11; 101(11):4283-4289.
-
Srivastava T, Krudys J, Mardis NJ, Sebestyen-VanSickle J, Alon US. Cinacalcet as adjunctive therapy in pseudohypoparathyroidism type 1b. Pediatr Nephrol. 2016 May; 31(5):795-800.
|
People People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|